{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:37:07Z","timestamp":1771000627917,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.lfs.2012.12.009","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T06:31:15Z","timestamp":1358317875000},"page":"259-265","source":"Crossref","is-referenced-by-count":12,"title":["Combined antiallodynic effect of Neurotropin\u00ae and pregabalin in rats with L5-spinal nerve ligation"],"prefix":"10.1016","volume":"92","author":[{"given":"Ryohei","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Namba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Okai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2012.12.009_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.lfs.2012.12.009_bb0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.lfs.2012.12.009_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2012.12.009_bb0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(99)00111-6","article-title":"Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?","volume":"83","author":"Field","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2012.12.009_bb0025","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lfs.2012.12.009_bb0030","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2012.12.009_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3959(02)00322-6","article-title":"Spinal nerve injury activates prostaglandin synthesis in the spinal cord that contributes to early maintenance of tactile allodynia","volume":"101","author":"Hefferan","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2012.12.009_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","article-title":"An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat","volume":"50","author":"Kim","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2012.12.009_bb0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuroscience.2008.02.031","article-title":"Pharmacological characterization and gene expression profiling of an L5\/L6 spinal nerve ligation model for neuropathic pain in mice","volume":"153","author":"Kiso","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2012.12.009_bb0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1254\/jjp.29.479","article-title":"Decrease in pain threshold in SART stressed mice","volume":"29","author":"Kita","year":"1979","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.lfs.2012.12.009_bb0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1471-4159.2010.06625.x","article-title":"Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate","volume":"113","author":"Kumar","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.lfs.2012.12.009_bb0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pain.2006.05.012","article-title":"(L)-Phenylglycine, but not necessarily other \u03b12\u03b4 subunit voltage-gated calcium channel ligands, attenuates neuropathic pain in rats","volume":"125","author":"Lynch","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2012.12.009_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2210-4-14","article-title":"A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats","volume":"4","author":"McClelland","year":"2004","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.lfs.2012.12.009_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.lfs.2012.12.009_bb0080","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1213\/ane.0b013e31817e7a59","article-title":"The antiallodynic effect of Neurotropin is mediated via activation of descending pain inhibitory systems in rats with spinal nerve ligation","volume":"107","author":"Okazaki","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.lfs.2012.12.009_bb0085","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMe058039","article-title":"Combination therapy for neuropathic pain-which drugs, which combination, which patients?","volume":"352","author":"Raja","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lfs.2012.12.009_bb0090","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1213\/01.ANE.0000160582.25368.B9","article-title":"The antiallodynic and antihyperalgesic effects of Neurotropin in mice with spinal nerve ligation","volume":"101","author":"Suzuki","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.lfs.2012.12.009_bb0095","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.neuropharm.2007.08.013","article-title":"Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model","volume":"53","author":"Takeuchi","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2012.12.009_bb0100","series-title":"Drug synergism and dose-effect data analysis","author":"Tallarida","year":"2000"},{"key":"10.1016\/j.lfs.2012.12.009_bb0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","article-title":"Interaction index: a measure of drug synergism","volume":"98","author":"Tallarida","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2012.12.009_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel \u03b12\u03b4 (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.lfs.2012.12.009_bb0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2005.11.001","article-title":"Activity profile of pregabalin in rodent models of epilepsy and ataxia","volume":"68","author":"Vartanian","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.lfs.2012.12.009_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T13:56:22Z","timestamp":1539957382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320513000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":23,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0024320513000106"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2012.12.009","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}